Literature DB >> 14985058

Carbon monoxide inhibits endothelin-1 release by human pulmonary artery smooth muscle cells.

Salome J Stanford1, Matthew J Walters, Jane A Mitchell.   

Abstract

Endothelin-1 is a potent vasoconstrictor with mitogenic properties. This 21-amino-acid protein, released in the vasculature by endothelial and smooth muscle cells, has been implicated in pulmonary hypertension. More recently, evidence has accumulated for a role of the heme oxygenase system in pulmonary hypertension. Heme oxygenase catalyses the breakdown of heme to produce carbon monoxide, biliverdin and free iron. Here we show that a carbon monoxide-releasing molecule, but not biliverdin, inhibits endothelin-1 release from serum-stimulated human pulmonary artery smooth muscle cells. Under certain conditions, carbon monoxide appears to act as an endogenous break on endothelin-1 release.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985058     DOI: 10.1016/j.ejphar.2003.12.026

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

Review 1.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

2.  Heat shock preconditioning reduces ischemic tissue necrosis by heat shock protein (HSP)-32-mediated improvement of the microcirculation rather than induction of ischemic tolerance.

Authors:  Yves Harder; Michaela Amon; Rene Schramm; Mirko Georgi; Andrej Banic; Dominique Erni; Michael D Menger
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

Review 3.  HO-1 overexpression and underexpression: Clinical implications.

Authors:  George S Drummond; Jeffrey Baum; Menachem Greenberg; David Lewis; Nader G Abraham
Journal:  Arch Biochem Biophys       Date:  2019-08-16       Impact factor: 4.013

Review 4.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

Review 5.  Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome.

Authors:  Nader G Abraham; Joshua M Junge; George S Drummond
Journal:  Trends Pharmacol Sci       Date:  2015-10-26       Impact factor: 14.819

6.  Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats.

Authors:  Eric M George; Marietta Arany; Kathy Cockrell; Megan V Storm; David E Stec; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-24       Impact factor: 3.619

Review 7.  [Carbon monoxide--poison or potential therapeutic?].

Authors:  A Hoetzel; R Schmidt
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

8.  Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the 'silent killer'.

Authors:  Prabal Kumar Chatterjee
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 9.  Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.

Authors:  Leo E Otterbein; Roberta Foresti; Roberto Motterlini
Journal:  Circ Res       Date:  2016-06-10       Impact factor: 17.367

Review 10.  Application of carbon monoxide for treatment of acute kidney injury.

Authors:  Atsunori Nakao; Taihei Yamada; Keisuke Kohama; Norichika Yoshie; Noritomo Fujisaki; Joji Kotani
Journal:  Acute Med Surg       Date:  2014-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.